Browse by region

World Map Middle East Africa South Asia Asia/Pacific Europe South America North America

National Institute of Health Awards Contract to Support Use of iBio’s Proprietary Technology for Improved Anthrax Vaccine

(Sacramento Bee) In October 2012, iBio announced issuance of a U.S. patent covering compositions of matter and methods of producing anthrax vaccines, an expansion of the Company’s portfolio of assets relevant to bio-defense and infectious disease product applications. Data previously published in peer-reviewed scientific journals demonstrated the effectiveness of the iBioLaunch  Read More »

Time and Money Are Being Wasted in the Lab

(The Chronicle) Advances across virtually all fields of science show promise for solving an array of puzzles about the nature of the world—from disease emergence and climate-change impact to the origins of our universe. Unfortunately, the pace of scientific progress is being slowed by excessive, redundant, and ineffective requirements imposed both  Read More »

Predicting, preventing, and controlling pandemics: Making the case for a strategic action plan

(EurekAlert) About 60% of infectious diseases are caused by viruses, bacteria and other pathogens that make the jump to humans from other species. This includes some of the most devastating disease outbreaks of the past 30 years, including HIV/AIDS, Ebola, and SARS. Despite the huge and rising toll of such diseases,  Read More »

Scientists Air Worries Over Proposed Rules on Avian Influenza Studies

(Global Security Newswire) The Obama administration last week rolled out a system to assess the potential benefits and threats of certain avian influenza studies and possibly mandate nondisclosure of some research activities, prompting worried responses over the measure’s potential to inhibit future research, Science magazine reported on Friday. National Institutes of Health  Read More »

Recombinant Production of Carrier Proteins

(Genetic Engineering News) Within the rapidly growing vaccine space, conjugate vaccines—polysaccharide antigens covalently linked to carrier proteins—have been shown to be effective against several bacterial pathogens. Conjugate vaccines use carrier proteins to increase the immunogenicity of antigens (e.g., peptides, oligosaccharides, polysaccharides) and other haptens. These antigens are poor immunogens unless conjugated  Read More »